IL1 Receptor Antagonist Inhibits Pancreatic Cancer Growth by Abrogating NF-κB Activation.
Zhuang Z, Ju HQ, Aguilar M, Gocho T, Li H, Iida T, Lee H, Fan X, Zhou H, Ling J, Li Z, Fu J, Wu M, Li M, Melisi D, Iwakura Y, Xu K, Fleming JB, Chiao PJ.
Zhuang Z, et al.
Clin Cancer Res. 2016 Mar 15;22(6):1432-44. doi: 10.1158/1078-0432.CCR-14-3382. Epub 2015 Oct 23.
Clin Cancer Res. 2016.
PMID: 26500238
Free PMC article.